Open AccessAbstract 4626: Use of integrated genomic analyses in patient-derived tumor model to discover new clinical indications for the multikinase inhibitor drug candidate, DBPR216
Author(s) -
ChingChuan Kuo,
WeirTorn Jiaang,
JingJim Ou,
ChiungTong Chen,
Shu-Shong Hsu,
Chuan Shih,
Limei Lin,
Manwu Sun,
Yi-Hsin Wang,
Zih-Ting Huang,
JuiChi Chang,
ShauHua Ueng
Publication year - 2019
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2019-4626
Subject(s) - sunitinib , medicine , regorafenib , imatinib , cancer research , drug , irinotecan , colorectal cancer , oxaliplatin , pdgfra , cancer , myeloid leukemia , pharmacology , oncology , gist , stromal cell